Icon

Aptensio XR - (10,15,20,30,40,50,60 mg; Capsule, Extended Release)

Methylphenidate Hydrochloride Rhodes Pharma
10,15,20,30,40,50,60 mg; Capsule, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Yes
******* ** *** ***** ** **** **** ** *** ********* ** **** ******* '***, ’***, ’***, ’***, ‘***, *** ’*** *** ******** ** *** **, ****. ****** ****** ***** * **** ******* ******* ** ******** ***** ** **. ****** *** ****** ** ** ****** ****, ********** *** ********* **** ******* ***** *** ***** ** ********* *** *** ***** *** ** ****** ** ** ** * ****** ****** *** **, **** ** ** ** *** **** ****** ********** *** ****.
Aptensio XR Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
******* ******* ******* ******* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ *** *** *, **** ******* ******** ******** ** *** **, ****
  1. *** **, **** : ******* ******** ****** ****** ***** *** **** ** **** ******* '***, ’***, ’***, ’***, ‘***, *** ’*** *** ******** ** *** **, ****.
  2. *** *, **** : ****** ***** * **** ******* ******* ** ******** ***** ** **.
  3. *** **, **** : ********** ********* **** ******* *** *** *** ******* ** ***** *.*. ******* '***, ’***, ’***, ’***, ‘***, *** ’*** *** ******** ** *** **, ****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.